Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1992 1
2008 2
2010 3
2011 4
2013 1
2014 1
2015 3
2016 2
2017 2
2018 3
2019 3
2020 2
2021 4
2022 1
2023 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

30 results

Results by year

Filters applied: . Clear all
Page 1
Breast-cancer adjuvant therapy with zoledronic acid.
Coleman RE, Marshall H, Cameron D, Dodwell D, Burkinshaw R, Keane M, Gil M, Houston SJ, Grieve RJ, Barrett-Lee PJ, Ritchie D, Pugh J, Gaunt C, Rea U, Peterson J, Davies C, Hiley V, Gregory W, Bell R; AZURE Investigators. Coleman RE, et al. N Engl J Med. 2011 Oct 13;365(15):1396-405. doi: 10.1056/NEJMoa1105195. Epub 2011 Sep 25. N Engl J Med. 2011. PMID: 21995387 Free article. Clinical Trial.
The revised Approved Instructional Resources score: An improved quality evaluation tool for online educational resources.
Grock A, Jordan J, Zaver F, Colmers-Gray IN, Krishnan K, Chan T, Thoma B, Alexander C, Alkhalifah M, Almehlisi AS, Alqahtani S, Anderson S, Anderson S, Andrews C, Andruko J, Antony N, Aryal D, Backus B, Baird J, Baker A, Batty S, Baylis J, Beaumont B, Belcher C, Benavides B, Benham M, Botta J, Berger Pelletier E, Bouchard N, Brazil V, Brumfield E, Bryson A, Bunchit W, Butler K, Buzikievich L, Calcara D, Carey R, Carrillo MR, Carroll S, Lyons C, Cassidy L, Challen K, Chan K, Chaplin T, Chatham-Zvelebil N, Chen E, Chen L, Chhabra S, Chin A, Chochi E, Choudhri T, Christensen J, Connors K, Coppersmith V, Cosgrove A, Costello G, Cullison K, D'Alessandro A, Wit K, Decock M, Delbani R, Denq W, Deutscher J, Devine B, Dorsett M, Duda T, Dueweke J, Dunphy T, Dyer S, Eastley KT, Edmonds M, Edwards K, Ehrman R, Elkhalidy Y, Fedor P, Ficiur B, Flynn C, Fraser B, Fu M, Fukakusa J, Funk E, Gaco D, Gawlik V, Ghaffarian K, Gharahbaghian L, Griffith A, Griffith P, Gronowski T, Grossman C, Gucwa J, Gupta P, Gustafson A, Guy A, Haas M, Haciski S, Hajdinjak E, Hall AK, Hammock R, Hansel J, Hart A, Hattin L, Herb B, Hilbert S, Hill J, Hill J, Ho A, House E, House N, Huang SYM, Huffman J, Inboriboon C, … See abstract for full author list ➔ Grock A, et al. Among authors: walji n. AEM Educ Train. 2021 May 16;5(3):e10601. doi: 10.1002/aet2.10601. eCollection 2021 Jul. AEM Educ Train. 2021. PMID: 34141997 Free PMC article.
HER2-enriched subtype and novel molecular subgroups drive aromatase inhibitor resistance and an increased risk of relapse in early ER+/HER2+ breast cancer.
Bergamino MA, López-Knowles E, Morani G, Tovey H, Kilburn L, Schuster EF, Alataki A, Hills M, Xiao H, Holcombe C, Skene A, Robertson JF, Smith IE, Bliss JM, Dowsett M, Cheang MCU; POETIC investigators. Bergamino MA, et al. EBioMedicine. 2022 Sep;83:104205. doi: 10.1016/j.ebiom.2022.104205. Epub 2022 Aug 16. EBioMedicine. 2022. PMID: 35985932 Free PMC article.
30 results